GU Update Ribeirão Preto is now in its third edition!
This course will cover the latest developments in the treatment of genitourinary tumors in the fields of surgery, clinical oncology, and radiation oncology. It will focus primarily on the latest findings from the 2026 ASCO Genitourinary Cancers Symposium.
We will cover three sections:
• Prostate Cancer
• Bladder Cancer
• Kidney Cancer
We will be joined by nationally renowned speakers, moderators, and panelists.
You're our special guest—come join us!
Dr. Júlia De Stéfani and Dr. Fábio Zola
Program Coordinators
March 21, 2026.
8:00 a.m. to 12:30 p.m.
TRYP by Wyndham
Room: Santos Dumont
Address: Av. Dr. José Cesário Monteiro da Silva, 150 - Jardim Nova Alianca, Ribeirão Preto - SP
Clinical Oncologists, Urologists, Radiation Oncologists, Pathologists, and medical residents.
Clinical Oncologist – São Paulo, SP | CRM 126540, RQE 45390
Clinical Oncologist – São Paulo, SP | CRM 126540, RQE 45390
Clinical Oncologist – Barretos, São Paulo | CRM 168127, RQE 90299
Clinical Oncologist – Barretos, São Paulo | CRM 168127, RQE 90299
Clinical Oncologist – Brasília/DF – CRM 23440, RQE 19007
Clinical Oncologist – Brasília/DF – CRM 23440, RQE 19007
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 157519, RQE 77458
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 157519, RQE 77458
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 92536, RQE 23178
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 92536, RQE 23178
Urologist – Ribeirão Preto, São Paulo | CRM 67294, RQE 57869
Urologist – Ribeirão Preto, São Paulo | CRM 67294, RQE 57869
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 145861, RQE 102461
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 145861, RQE 102461
Uro-Oncologist – Ribeirão Preto, São Paulo | CRM 94246, RQE 58781
Uro-Oncologist – Ribeirão Preto, São Paulo | CRM 94246, RQE 58781
Geriatric Oncology – Ribeirão Preto, São Paulo | CRM 209983, RQE 116558
Geriatric Oncology – Ribeirão Preto, São Paulo | CRM 209983, RQE 116558
Urologist – Ribeirão Preto, São Paulo | CRM 144377, RQE 60593
Urologist – Ribeirão Preto, São Paulo | CRM 144377, RQE 60593
Radiation Oncologist – Ribeirão Preto, São Paulo | CRM 156806, RQE 67820
Radiation Oncologist – Ribeirão Preto, São Paulo | CRM 156806, RQE 67820
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 175832
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 175832
Radiation Oncologist – Ribeirão Preto, São Paulo | CRM 108563, RQE 39279/40017
Radiation Oncologist – Ribeirão Preto, São Paulo | CRM 108563, RQE 39279/40017
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 89701, RQE 75984
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 89701, RQE 75984
Urologist – Ribeirão Preto, São Paulo | CRM 116423, RQE 33267
Urologist – Ribeirão Preto, São Paulo | CRM 116423, RQE 33267
Urologist – Ribeirão Preto, São Paulo | CRM 176358, RQE 92238
Urologist – Ribeirão Preto, São Paulo | CRM 176358, RQE 92238
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 184981, RQE 100968
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 184981, RQE 100968
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 156838, RQE 102690
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 156838, RQE 102690
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 130109
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 130109
Urologist – Ribeirão Preto, São Paulo | CRM 63701, RQE 53657
Urologist – Ribeirão Preto, São Paulo | CRM 63701, RQE 53657
Urologist – Ribeirão Preto, São Paulo | CRM 135396, RQE 62932
Urologist – Ribeirão Preto, São Paulo | CRM 135396, RQE 62932
Urological Oncologist – Ribeirão Preto, São Paulo | CRM 117720, RQE 31712
Urological Oncologist – Ribeirão Preto, São Paulo | CRM 117720, RQE 31712
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 212669, RQE 109777
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 212669, RQE 109777
Clinical Oncologist – São Paulo, SP | CRM 114273, RQE 98490
Clinical Oncologist – São Paulo, SP | CRM 114273, RQE 98490
Clinical Oncologist – São Paulo, SP | CRM 115749, RQE 47479
Clinical Oncologist – São Paulo, SP | CRM 115749, RQE 47479
Clinical Oncologist – Salvador, Bahia | CRM 25221, RQE 15315
Clinical Oncologist – Salvador, Bahia | CRM 25221, RQE 15315
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 185624, RQE 132605
Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 185624, RQE 132605
Urologist – Ribeirão Preto, São Paulo | CRM 48746, RQE 44014
Urologist – Ribeirão Preto, São Paulo | CRM 48746, RQE 44014
8:00 a.m. – Breakfast – Meet the Professor
8:20 a.m. – Welcome and opening remarks: Dr. Júlia De Stéfani and Dr. Fábio Zola
8:30 a.m. – Prostate Cancer – What is the importance of assessing genomic mutations? Is mHRR testing alone sufficient? What tests should be performed in 2026?
Speaker: Dr. Carlos Fruet
08:45 – Advanced Prostate Cancer. Is it time for radioligand therapy (LuPSMA) at CPSCm?
Speaker: Dr. Luciola Pontes
09:00 – Minimizing Damage: Surgical approaches to preserve continence and sexual function in patients with prostate cancer.
Speaker: Dr. Tiago Bovo
09:15 – Under Discussion: Testosterone Replacement Therapy in patients with prostate cancer undergoing follow-up.
Speaker: Dr. Rodolfo Borges dos Reis
9:30 a.m. – Androgen deprivation in elderly patients: functional, cognitive, and metabolic impact—invisible effects that alter outcomes.
Speaker: Dr. Helena Palocci
9:45 a.m. – Discussion
Discussants: Dr. Thaís Carvalho and Dr. Murilo Andrade
10:00 a.m. – Bayer Satellite Symposium: CPHSm: From Intensification to Personalized Treatment
Speaker: Dr. Daniel Girardi
10:20 – Coffee Break
10:35 – High-risk non-muscle-invasive urothelial carcinoma of the bladder: the surgeon’s approach and discussion on combining immunotherapy with BCG?
Speaker: Dr. Gustavo Miranda
10:50 – Bladder preservation: where are we now, and where are we headed?
Speaker: Dr. Guilherme Mendes
11:05 – Enforfumabe vedotin and pembrolizumab in locally advanced or metastatic disease, and future prospects
Speaker: Dr. Fernanda Bombarda
11:20 – Discussion
Discussants: Dr. Daniel Girardi and Dr. Guilherme Franco
11:35 – AstraZeneca Satellite Symposium: NIAGARA in Practice: From Evidence to Clinical Experience with CBMI Patients
Speaker: Dr. Daniel Preto
12:05 – Beyond the Protocols: Strategic Decisions in the First-Line Treatment of Advanced Renal Cancer.
Speaker: Dr. Daniel Preto
12:20 – Discussion
Panelists: Dr. Priscila Pavanelli, Dr. Luciola Pontes, and Dr. Daniel Girardi
12:30 p.m. – Closing Remarks: Dr. Fábio Zola and Dr. Júlia De Stéfani
Lunch will be served at the hotel restaurant
